Growth after pediatric liver transplantation is an important factor in
determining the quality of life. We collected data on height, skeleta
l age, and liver function of 45 consecutive pediatric transplant recip
ients and assessed the influence of primary diagnosis, liver function,
and immunosuppressive regimen on their growth. Height and skeletal ag
e were plotted as median standard deviation scores versus years post-t
ransplantation. Growth, in terms of both height and skeletal age, were
continuous without catch-up growth. Primary diagnosis was found to ha
ve no influence on height and poor liver function had a negative effec
t on both height and skeletal growth. A higher alternate day prednisol
one maintenance dose also had a negative effect on skeletal growth. Th
us, it can be concluded that a pretransplant lack of growth will not b
e restored and is an indication for early transplantation in endstage
liver disease, especially in younger children.